The GLP-1 medications currently approved and used in clinical practice, primarily for the treatment of type 2 diabetes and obesity, include: Semaglutide: Ozempic, Wegovy, Rybelsus Tirzepatide: Mounjaro, Zepbound Liraglutide: Victoza, Saxenda Dulaglutide: Trulicity Exenatide: Byetta, Bydureon Expanding Beyond Obesity The therapeutic potential of GLP-1s extends beyond weight management
Keep Learning About Your Hormone Health Real answers to the questions our patients ask most, written by the team behind your care
Melanoma antigen-like gene 2 ( MAGEL2 ) Mutation of MAGEL2 leads to the development of Prader-Willi Syndrome (PWS), a genetic disease that causes obesity and mental retardation [162]
Clinical and meta-analytic data indicate that, although FBM reduction predominates, modest decreases in LBM can occur, particularly during substantial weight loss [17, 18]
Long-Term Usability Approved for chronic weight management, Semaglutide supports sustainable lifestyle changes over time
If you are taking oral semaglutide (Rybelsus), it is advised to take it 30 minutes before your first food, beverage, or other oral medications of the day with a small amount of water